Related Experiment Video
Updated: Jun 5, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Simvastatin represses protein synthesis in the muscle-derived C₂C₁₂ cell line with a concomitant reduction in
Alexander P Tuckow1, Sarah J Jefferson, Scot R Kimball
1Dept. of Cellular & Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
Abstract:
Statins are a widely prescribed class of cholesterol lowering drugs whose use is frequently associated with muscle-related ailments. A number of mechanisms have been implicated in statin-induced myotoxicity including alterations in both protein synthesis and protein degradation. The objective of the present study was to explore the mechanism(s) contributing to the statin-induced reduction in protein synthesis in the muscle-derived C₂C₁₂ cell line. Cells were treated with 10 microM simvastatin or vehicle alone for 24 h in 1% serum. Cells exposed to simvastatin exhibited reduced rates of protein synthesis, as evidenced by [(35)S]methionine and [(35)S]cysteine incorporation into protein. The reduction in protein synthesis occurred with a concomitant decrease in expression and activity of eukaryotic initiation factor 2B (eIF2B), a regulated and rate-controlling guanine nucleotide exchange factor known to affect global rates of protein synthesis. The reductions in protein synthesis and eIF2B expression were prevented by coincubation with mevalonate. Simvastatin treatment also resulted in a proteasome-sensitive reduction in the protein expression of all the subunits of the eIF2B heteropentameric complex. Finally, increased phosphorylation of the catalytic ε-subunit at Ser(535) was observed, an event consistent with an observed reduction in eIF2B activity. These results suggest that repression of eIF2B expression and activity may contribute, at least in part, to the statin-induced reduction in protein synthesis.
Insights
Statins reduce muscle protein synthesis by decreasing eukaryotic initiation factor 2B (eIF2B) expression and activity. This effect, linked to statin-induced myotoxicity, was reversed by mevalonate.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Statins, widely used cholesterol-lowering drugs, are associated with muscle-related side effects (myotoxicity).
- Mechanisms of statin-induced myotoxicity involve disruptions in muscle protein synthesis and degradation pathways.
Purpose of the Study:
- To investigate the molecular mechanisms underlying statin-induced reduction in protein synthesis in muscle cells.
- To explore the role of eukaryotic initiation factor 2B (eIF2B) in simvastatin-induced myotoxicity.
Main Methods:
- C₂C₁₂ muscle cells were treated with simvastatin (10 microM) or vehicle.
- Protein synthesis rates were measured using [(35)S]methionine and [(35)S]cysteine incorporation.
- Expression and activity of eIF2B, and phosphorylation of its ε-subunit, were assessed.
- Proteasome sensitivity was evaluated.
Main Results:
- Simvastatin treatment significantly reduced protein synthesis rates in C₂C₁₂ cells.
- A decrease in both the expression and activity of eukaryotic initiation factor 2B (eIF2B) was observed.
- Mevalonate co-incubation prevented the simvastatin-induced reductions in protein synthesis and eIF2B levels.
- Simvastatin induced a proteasome-sensitive decrease in eIF2B protein expression and increased phosphorylation of the eIF2B ε-subunit.
Conclusions:
- Repression of eIF2B expression and activity is a key mechanism contributing to statin-induced reduction in muscle protein synthesis.
- These findings provide insights into the molecular basis of statin-induced myotoxicity.
- Targeting eIF2B regulation may offer strategies to mitigate statin-associated muscle problems.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulation of Nuclear Protein Sorting
Regulation of Expression at Multiple Steps
